Karyopharm Therapeutics Inc. ( KPTI) - Stock Earnings
KPTI Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 2, 2026, midnight | — / — | — | — / — | — |
KPTI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -102.2 million USD | 34.1 million USD |
| 2026Q1 | -22.4 million USD | 35.1 million USD |
| 2026Q2 | -67.0 million USD | 33.4 million USD |
| 2027Q2 Est. | — | — |
KPTI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -143.1 million USD | 146.0 million USD |
| 2024 | -76.4 million USD | 145.2 million USD |
| 2025 | -196.0 million USD | 146.1 million USD |
| 2026 Est. | — | — |
KPTI
Price: $0.55
52 week price:
Earnings Per Share: -14.33 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Ebitda: -30.9 millionMarket Capitalization: 18.2 million